In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates.
about
Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungalDeterminants of disease presentation and outcome during cryptococcosis: the CryptoA/D studyEfficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosisComparative effectiveness of induction therapy for human immunodeficiency virus-associated cryptococcal meningitis: a network meta-analysis.Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans.In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreusEpidemiology and management of cryptococcal meningitis: developments and challenges.Inhibition of nucleotide biosynthesis potentiates the antifungal activity of amphotericin B.Pharmacotherapy of cryptococcosis.Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus.De Novo Pyrimidine Biosynthesis Connects Cell Integrity to Amphotericin B Susceptibility in Cryptococcus neoformans.
P2860
Q27012487-16ED74E3-7E66-4876-8C0F-0E9A81271D1BQ33272469-9D46AA75-274B-44F5-8CB2-21F8DF4F31A2Q34301547-8D16FA25-9BD9-47E0-B378-5742A3F71CB4Q34721673-E9A8D982-40CC-40CA-A70C-24C16E65AD94Q35628245-0ECAFF00-879E-469A-9A05-215191FF8E5FQ35635773-6265073D-F767-4ABC-B364-27FC0ECF1133Q36492208-92CD70BD-0127-43E2-8D17-3A25743DBF5BQ37098995-A4233D5E-4E01-435C-94E3-CAEB7E1260B6Q37534681-C32ACE39-207E-4688-A6FA-C8E8B1A9C8E0Q37587230-9E4997E5-2336-4838-9D48-11BA86FBF993Q38154164-8AC6F2F2-9FDD-4754-A8CF-BC0494C3CA8FQ41772012-C88FE5DE-0C8D-4C0C-AB71-C6BC608B008EQ42114923-2422BBD3-E0FC-437B-A879-377FA0B14C5D
P2860
In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
In vitro interaction of flucyt ...... neoformans clinical isolates.
@ast
In vitro interaction of flucyt ...... neoformans clinical isolates.
@en
type
label
In vitro interaction of flucyt ...... neoformans clinical isolates.
@ast
In vitro interaction of flucyt ...... neoformans clinical isolates.
@en
prefLabel
In vitro interaction of flucyt ...... neoformans clinical isolates.
@ast
In vitro interaction of flucyt ...... neoformans clinical isolates.
@en
P2860
P1476
In vitro interaction of flucyt ...... s neoformans clinical isolates
@en
P2093
Françoise Dromer
Olivier Lortholary
P2860
P304
P356
10.1128/AAC.47.10.3361-3364.2003
P407
P577
2003-10-01T00:00:00Z